ARCH Venture Fund XII, L.P., 10% Owner at Prime Medicine, Inc. (PRME), bought 3,030,300 shares at $3.30 ($10.0M) on 2025-08-01, disclosed to the SEC on 2025-08-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |